Jan 23 (Reuters) - BASILEA PHARMACEUTICA AG:
* BASILEA REPORTS ACTIVITY OF DERAZANTINIB IN PRECLINICAL MODELS OF GASTRIC CANCER AT ASCO GASTROINTESTINAL CANCERS SYMPOSIUM Source text for Eikon: Further company coverage: (Gdansk Newsroom)
Our Standards: The Thomson Reuters Trust Principles.